Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Topical Treatment Response With Amitriptyline and Ketamine: Combination Trial in Chemotherapy Peripheral Neuropathy (ATTRACT-CPN)

NCT00471445 is registered in ClinicalTrials.gov with Gary Morrow as lead sponsor.

NCT NCT00471445
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00471445 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Topical Treatment Response With Amitriptyline and Ketamine: Combination Trial in Chemotherapy Peripheral Neuropathy (ATTRACT-CPN)
Lead sponsor
Gary Morrow
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2007
Completion date
November 30, 2013
Enrollment
462 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

neurotoxicity, pain, peripheral neuropathy, unspecified adult solid tumor, protocol specific